Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Herrera Malaga Adolfo
   2. Issuer Name and Ticker or Trading Symbol
BENTLEY PHARMACEUTICALS INC [BNT] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Managing Director European Ops
(Last)
(First)
(Middle)
BENTLEY PARK, 2 HOLLAND WAY		 3. Date of Earliest Transaction (Month/Day/Year)
05/23/2007
(Street)

EXETER, NH 03833		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.02 par value 05/23/2007   M   2,125 (1) A $ 0 19,625 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Right to purchase $ 11.965 05/23/2007   A   50,000     (2) 05/23/2017 Common Stock, $0.02 par value 50,000 $ 0 50,000 D  
Restricted Stock Units (3) 05/23/2007   A   9,000     (4)   (4) Common Stock, $0.02 par value 9,000 $ 0 9,000 D  
Restricted Stock Units (3) 05/23/2007   M     2,125   (5)   (5) Common Stock, $0.02 par value 2,125 $ 0 6,375 D  
Right to purchase $ 2.375               (6) 06/15/2008 Common Stock, $0.02 par value 7,000   7,000 D  
Right to purchase $ 5.875               (7) 01/03/2010 Common Stock, $0.02 par value 25,000   25,000 D  
Right to purchase $ 6               (8) 05/09/2011 Common Stock, $0.02 par value 50,000   50,000 D  
Right to purchase $ 9.79               (9) 01/03/2012 Common Stock, $0.02 par value 50,000   50,000 D  
Right to purchase $ 8.05               (10) 01/01/2013 Common Stock, $0.02 par value 30,000   30,000 D  
Right to purchase $ 10.04               (11) 05/21/2013 Common Stock, $0.02 par value 30,000   30,000 D  
Right to purchase $ 13.3               (12) 01/01/2014 Common Stock, $0.02 par value 75,000   75,000 D  
Right to purchase $ 7.5               (13) 03/30/2015 Common Stock, $0.02 par value 70,000   70,000 D  
Right to purchase $ 11.775               (14) 05/23/2016 Common Stock, $0.02 par value 43,300   43,300 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Herrera Malaga Adolfo
BENTLEY PARK
2 HOLLAND WAY
EXETER, NH 03833		       Managing Director European Ops

Signatures

 Adolfo Herrera Malaga   05/25/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents shares received from the vesting of restricted stock units.
(2) Options were granted under terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Grant becomes exercisable in three equal installments 5/23/2008, 5/23/2009 and 5/23/2010.
(3) Each restricted stock unit represents a contingent right to receive one share of Bentley Pharmaceuticals, Inc. Common Stock, $0.02 par value.
(4) Restricted stock units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Units vest, and will be issued to the reporting person, in four equal installments on 5/23/2008, 5/23/2009, 5/23/2010 and 5/23/2011.
(5) Restricted stock units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Remaining units vest, and will be issued to the reporting person, in three equal installments on 5/23/2008, 5/23/2009 and 5/23/2010.
(6) Options were granted under terms of the Company's 1991 Stock Option Plan. Grant became exercisable on 6/15/1999.
(7) Options were granted under terms of the Company's 1991 Stock Option Plan. Grant became exercisable on 1/3/2001.
(8) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable on 5/9/2002.
(9) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 1/3/2003 and 1/3/2004.
(10) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 1/1/2004 and 1/1/2005.
(11) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 5/21/2004 and 5/21/2005.
(12) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 1/1/2005 and 1/1/2006.
(13) Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in three equal installments on 3/30/2006, 3/30/2007 and 3/30/2008.
(14) Options were granted under terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Grant becomes exercisable in three equal installments 5/23/2007, 5/23/2008 and 5/23/2009.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.